CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population

Hongxue Xu,Zhenbang Yang,Wenqian Hu,Xianlei Zhou,Zhi Zhang,Xuemei Zhang
DOI: https://doi.org/10.1186/s12885-024-12475-4
IF: 4.638
2024-06-15
BMC Cancer
Abstract:Chondroitin sulfate proteoglycan 4 pseudogene 12 ( CSPG4P12 ) has been implicated in the pathogenesis of various cancers. This study aimed to evaluate the association of the CSPG4P12 polymorphism with esophageal squamous cell carcinoma (ESCA) risk and to explore the biological impact of CSPG4P12 expression on ESCA cell behavior.
oncology
What problem does this paper attempt to address?